Jump to content


Most Liked Content


#7133 Closed form vs differential equation

Posted by cmukashyaka on 30 November 2023 - 04:30 PM

Hello,

I am running a 2-compartment linear model, when I don't click closed form to use differential equations, the model is not converging with error message:

 

Initial parameter values result in -LL = NaN

 Restart from new values
Error: Model Exception: Fortran Exception
NlmeErrorExit: close files and exit(0).
 
Additionally, initial estimates graphs have some subjects with negative concentrations. I change initial estimates to no avail. 
 
However, when I run the exact same model in closed form, the model runs fine and I get descent fits and parameter estimates with good CV%. 
 
Anyone else experienced this? 

Attached Files


  • WalterNic, ??????????????? ??????, DanielGon and 12 others like this


#7394 covariate

Posted by linda on 21 March 2024 - 08:22 PM

Hi all, 

1. What method does Phoenix use to assess significance of covariate relationships with PK parameters in pop PK model?

 

2. After I add a binary categorical covariate to the model. In the result tab, I can get a boxplot of "eta with cov" and "str with cov". What method did Phoenix to generate those plots and  Can I use those plots to assess the signification of correlation?

 

Thanks,

Linda


  • Stevensi, AlexKawn, RonaldAxon and 11 others like this


#7046 Covariate effect explanation

Posted by Davidq8 on 03 August 2023 - 10:59 PM

Hello, I have a question about communicating the covariate impact to people who are unfamiliar with the Nonlinear mixed effect methodology used in PopPk analysis.

So, suppose we have body weight influencing drug (X) clearance, and an increase in body weight is associated with a decrease in CL, with the impact estimated by the model (- 0.5).

Can we say that increasing body weight by 10 kg intervals results in a 5% reduction in drug clearance?


Thanks     


  • RandyLof, Michaelnof, DanielGon and 11 others like this


#1833 calculating inter-individual variability

Posted by Lance Wollenberg on 23 July 2013 - 10:31 PM

Hi,

 

My colleagues and I were having a discussion on calculations regarding the omega and omegastderr output and getting this into useful terms that can help you better understand the variability for the purposes of reporting. We are hoping experts in the extranet community could help to clarify.

 

I know that the output on the omega block generates a variance.

 

For proportional/exponential error models

CV=sqrt(omega)*100

 

For additive error models

SD=sqrt(omega)

 

Are these conventions correct dependent the error model structure you select?

 

For the omegastderr, how does this term relate to the final parameter estimate? What math is involved to get this into an %RSE term?

 

To our understanding, for a given parameter

%RSE=(Omegastderr)/SQRT(Omega)*100

 

Is this correct? From what I can tell this is different than the calculation that is done with NONMEM output. Any insight would be greatly appreciated.

 

Lance


  • Micaela Reddy, RandyLof, DonaldCLILE and 11 others like this


#7194 Log-transformed plasma concentration-time profiles

Posted by Davidq8 on 06 February 2024 - 05:54 PM

Hello, I am working on a model, and I need to test the model with plasma concentration to be log-transformed.

Is there an option in the software to transform drug exposure data from normal scale to log scale, or should it be done first before uploading the dataset?

Also, How can I transform estimated PK parameters back to normal scale after the analysis using the software?

 


  • DonaldCLILE, DanielGon, BrandonPef and 10 others like this


#7055 Change the time format

Posted by weizixu on 23 August 2023 - 08:31 PM

Hi, 

 

How can I change time format "10/Dec/2014" to"10/12/2014"? 

I tried to use data wizard "datevalue" function, but to read it back to "dd/mm/yy" format. Thanks! 


  • Paulawrilm, Samuelded, Albertsnarm and 10 others like this


#7145 Using observed baselines values as fixed parameter value

Posted by cmukashyaka on 12 December 2023 - 10:06 PM

Hello,

I am working on an indirect response model (limited inhibition of Kin), I have baseline values for each subject measured at the start of study. I need to use these values and fix them as E0 where E0 = Kin/Kout so that I can only estimate either Kin or Kout but not both at the same time.

I think there is a way to have these baseline values in a separate column in dataset and set them as covariate in the model code text. Can someone please help me with an example PML code that I can use to accomplish this? 

For dataset, do I add these at each timepoint for each individual as I would for other covariates or only at time=0 where they are actually measured?

 

If my thinking of approaching this is off, how can I take care of this? I don't want to fix E0 to a single value without implementing the interindividual variability observed with baseline measurements. 

 

Thanks a lot


  • Natalinak, AaronToots, RandyLof and 9 others like this


#7285 Fraction Drug Dissolved (FRD) and Fraction Drug Absorbed (FRA)

Posted by rezkighassani on 29 February 2024 - 01:35 PM

Greetings,

 

I would like to ask what is the difference between Fraction Drug Dissolved and Fraction Drug Absorbed? Then how to calculate these 2 parameters.
 
Thank you.

  • ppu-prof_Pn, DanielGon, AlexKawn and 8 others like this


#7108 Synthetic Gradients

Posted by Davidq8 on 08 November 2023 - 02:42 AM

Hello, I have a question regarding the option to use synthetic gradients while running a model. 
I found in the instruction manual that activating this option may improve speed and accuracy, however it is not the default configuration when running a model.
My question is whether I should expect a difference in estimated model parameters if I choose this option instead of the default setting.
Thanks 

Run_Options_tab.png


  • Timothydrift, DanielGon, Thomasgaks and 8 others like this


#7130 Help needed for higher %cv

Posted by Trutino on 29 November 2023 - 09:25 PM

Hi Experts,

 

Could you please give me some suggestions about my mistake when running modeling?

 

why is the %CV so high in the Theta sheet? 

 

Appreciate your help!

 

Drug administration by IV and dosage is 0.9mg/kg. Cmax=19ug/mL.

 

 

 

 

 


  • AlexKawn, Hubertnop, Zacharysaund and 7 others like this


#7118 Copy Plots as High Resolution Image (vector) - Issues

Posted by danielcoliveira4 on 13 November 2023 - 04:54 PM

Hello,

 

I am attempting to save relevant modeling plots as vector images. I have tried a couple of things without success

 

1. Print PDF (does not show up as vector image)

2. Export as JP or PNG (these are not vector files)

3. Copy high resolution image and paste to word document - this does produce a vector image but it is cut off (see file attachment).

 

Anyone else encounter this issue? Trying to fix this instead of using a third-party licensed program to convert the non-vector output into vector

 

 

 

Attached Thumbnails

  • snip.PNG

  • RandyLof, WalterNic, Stevensi and 7 others like this


#7072 Continuous covariate with zero value

Posted by Davidq8 on 19 September 2023 - 10:02 PM

Hello, I'm working on a model and trying to determine how a continuous covariate would affect the Pk parameters of a drug.
 
This covariate has a value of zero for some subjects and an integer value "above zero" for other subjects.
 
Even though eta plots demonstrate a significant correlation between the value of this covariate and Pk parameters, I don't get any iterations when I conduct stepwise analysis to evaluate the impact of this covariate on the drug parameters.
 
Does that imply that the continuous covariates must always have a value greater than zero ?

  • Stevensi, Thomasgaks, RonaldAxon and 7 others like this


#7063 Limits to EObs

Posted by frrd@lundbeck.com on 06 September 2023 - 09:15 AM

I have some activity data from mice in time bins. The observed data is in percent of time they are mooving. If the mice are stimulated many will move around 100% of the time. However, some of the mice that moove 100% of the time are more stimulated than others so we observe a ceiling effect. So the real Emax is higher than the observed Emax which is limited by a ceiling of the measurements. I would like to convert my PD model with a ceiling effect so that. eg (0,0.3,0.9,1.2,1.5) preddicted from the model is converted to (0.30,90,100,100). I tried

 

logit(Emax*E/EC50+E)

 

or 

 

E= ln (EB / (1 - EB))

EB= Emax*E/EC50+E

 

However both ln and logit does not work in the model structure. Is there another way to do this effect prediction with a ceiling? 

 

BR Frederik


  • Michaelnof, DanielGon, AlexKawn and 7 others like this


#2647 Welcome to the new forum - some tips..

Posted by Simon Davis on 23 October 2014 - 08:38 AM

I thought it would be useful to put a few comments explaining what you should see in this new forum and how to use it. 

 

First off you should see better search within the forum as well as indexing by Google and other search engines.

 

One of the big improvements is the option to get instantaneous notifications of new posts or if you prefer daily or weekly 'digests'.  However to obtain these you have to ‘follow’ the forum(s) of interest. 

 

follow.jpg

 

To this end we have reduced the number of categories make this easier to follow your interests;

 

Phoenix WinNonlin Basics - to discuss NCA, data tools, tables, templates, also Reporter

 

Modelling & Simulation - using the Phoenix engine in both population and individual problems

 

Advanced Phoenix features - this is aimed to help with primarily CONNECT functions i.e. configurations and interoperability so IT/power users who configure larger workflows using third party tools (i.e. R, PSN, NONMEM) or exchange data with other groups i.e. CDISC, PKS, AP, etc.

 

IVIVC applying this tool to guide formulation development, biowaivers etc.

 

QT+  performing rapid comprehensive analysis of ECG interval data from clinical trials, SimCYP’s Cardiac Safety Simulator etc

 

Lastly, during migration we may have lost some formatting or links to attachments - if you have a problem with an old post please let me know e.g. by Reporting the post and I'll try and get that information re-linked.

 

     Simon

 

PS feel free to ask other forum usage questions here.


  • Albertsnarm, Austingar, Hubertnop and 7 others like this


#7093 Reminder: Staging will be Upgraded to Integral v23.10.1 Friday 13th October,...

Posted by Simon Davis on 11 October 2023 - 11:45 AM

Lead users at each company should already have received this notification last month and reminder yesterday with Draft Release notes so check you junk folders if you have not seen this please.  If you want to be added to that distribution list then please contact me.

We will give a general session for all existing users to discuss these new features on Thursday at 10 am EST, the session will last no more than an hour and will be recorded.  You may register below.

 

https://certara.zoom...qQVO7EChtLx2Wnw

 

With the next release of Integral 23.10.1, Certara will release a new feature for its industry-leading data repository that will support data storage requirements where 21 CFR (Code of Federal Regulations) Part 11 signature compliance is not necessary. The feature will allow specifically licensed Integral users to interact with designated folder structures without needing to securely sign for every interaction.  This feature will be available to both fully licensed users and partners, and the feature will work in the same repository where eSignature can still be required for 21 CFR Part 11 clinical studies.

For our users to preview this,  on Friday, 13th October, we propose to upgrade www.integral-staging.certara.com/
to the 23.10.1 release candidate, please anticipate a short down time from 11a.m EDT when the repository will be unavailable.


User action will be required: 

Complete and save work, and logout before 11 am (EST)

The Phoenix Integral 23.10.1 plug-in (or Integral Client 23.10.1) will be required and we will distribute the download links shortly.
Be sure to use the most recent versions of Phoenix 8.2.2, or 8.3.4, 8.3.5 or 8.4 with 23.10.1, prior versions are not tested or supported with this version of Integral. 

 

Thanks, Simon DAVIS

Senior Manager, Support

 


  • DanielGon, AlexKawn, WilliamJainy and 6 others like this


#7081 Bootstrap Success Rate in Phoenix Software

Posted by Crystal on 10 October 2023 - 03:23 AM

Dear Forum Members,
 
I am currently working on a project involving bootstrap analysis, and when using the Nommem, I can find the successful rate of bootstrap simulations. However, I have not been successful in finding the specific location where the success rate of bootstrap simulations is displayed in Phoenix. I would be immensely grateful if someone could kindly guide me on where to find this particular result within the Phoenix software.
 
Any assistance or insights you can provide would be greatly appreciated. Thank you very much for your time and assistance.
 

  • DanielGon, Williamwrire, AlexKawn and 6 others like this


#6769 Parent drug with metabolites and GI pre-systemic metabolism

Posted by Davidq8 on 23 October 2022 - 12:24 AM

Hi
I am trying to build a PopPk model for a drug with its metabolite (active) as a joint model. I found a published model where they modeled the portion of the metabolite formed from the parent drug in GI (pre-systemic). I tried to build a similar model using the graphical interface option in NLME.
 
For pre-systemic metabolism, I created a deposit compartment using the (Duration) function in the absorption compartment and then two absorption rates, one to the central compartment of the parent drug and another directly to the central compartment of the metabolite. I am unsure if this defined the pre-systemic metabolism step described in the published model.
 
The other issue, I am trying to model the fraction of parent drug clearance attributed to metabolite formation and the fraction to other not active metabolites (not needed to be included in the model). I do not know how to do that using NLME. 
 
Can I get help with this issue?
 
I attached the model file I created and the pharmacokinetic model structure for the published paper. 

Attached Thumbnails

  • Model.jpg

Attached Files


  • Cyharlesbob, DanielGon, WilliamJainy and 6 others like this


#7383 How to calculate IV and PO PK parameters

Posted by hyton07 on 19 March 2024 - 09:05 PM

I am new to the software. I would like to use Winnonlin to calculate the PK parameters for IV and PO in the same file. How do I do that? Thank you

Attached Files


  • Stevensi, RonaldAxon, Austingar and 5 others like this


#7375 How to introduce correlations between random effects?

Posted by CryptoCurrencySmite on 19 March 2024 - 05:50 PM

Can we explore the impact of introducing correlations between random effects in PK/PD modeling on the accuracy of predictions and the understanding of complex drug disposition mechanisms?


  • Paulawrilm, DanielGon, Donaldjet and 5 others like this


#7192 Virtual Patients Simulation

Posted by linda on 02 February 2024 - 11:07 PM

Hi,

 

If I have a phxproj file for a pop PK model fitting. How can I use RsNLME to simulate 100 virtual patients based on fitted pop PK parameters?

 

Thanks,

Linda


  • Timothydrift, PhilipNup, RandyLof and 5 others like this